CervoMed
Price & Volume
Stats
See moreOpen | $10.41 |
Previous Close | $10.71 |
Day Range | $8.72-$10.41 |
52W Range | $1.80-$25.92 |
Market Cap | $93.2M |
Shares Short | 966,031 |
Financials
See moreRevenue (12 Mos) | $9.7M |
Revenue Growth (YoY) | -13.2% |
Gross Profit (12 Mos) | -$9M |
Diluted EPS | -$2.02 |
News
See moreYahoo Finance • 10 hours ago
CervoMed Announces Oral Presentation at 19th International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurologic Disorders (AP/PD™)
Yahoo Finance • 15 days ago
CervoMed Announces Positive Results from the Extension Phase of its Phase 2b Clinical Study of Neflamapimod in Patients with Dementia with Lewy Bodies
Yahoo Finance • 2 months ago
CervoMed to Present at the 8th International Lewy Body Dementia Conference
About
CEO | Dr. John J. Alam M.D. |
CFO | Mr. William Robert Elder J.D. |
Address | 20 Park Plaza, Boston, MA, United States, 02116 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 15 |
